Index of reports
> Life Threatening Events (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zonegran (Zonisamide) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zonegran side effects in 12 year old male
Reported by a pharmacist from United States on 2012-03-27
Patient: 12 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Grand MAL Convulsion, Viral Infection, Vomiting, Respiratory Failure, Nausea, General Physical Health Deterioration, Neutropenia, Pyrexia, Hypogammaglobulinaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zonegran
Other drugs received by patient: Lamictal
Possible Zonegran side effects in male
Reported by a physician from France on 2012-01-05
Patient: male
Reactions: Weight Decreased, Urinary Tract Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zonegran
Other drugs received by patient: Lamictal; Keppra
Possible Zonegran side effects in 40 year old female
Reported by a physician from France on 2011-11-29
Patient: 40 year old female
Reactions: Neutropenia, Anaemia Macrocytic, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Tegretol
Dosage: 800 mg daily
Administration route: Oral
Phenobarbital TAB
Dosage: 150 mg daily
Administration route: Oral
Vimpat
Dosage: 300 mg daily
Administration route: Oral
Zonegran
Dosage: 500 mg daily
Administration route: Oral
Possible Zonegran side effects in male
Reported by a pharmacist from United States on 2011-11-17
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Encephalopathy, Ammonia Increased, Convulsion
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Divalproex Sodium
Dosage: depakote 1500mg daily po
Administration route: Oral
Indication: Epilepsy
Start date: 2011-11-04
End date: 2011-11-09
Zonegran
Dosage: zonegran 500mg daily po
Administration route: Oral
Indication: Epilepsy
Start date: 2011-05-01
End date: 2011-11-09
Other drugs received by patient: Abilify
|